Can-Fite BioPharma logo

Can-Fite BioPharma

CANF | AMEX
Chart Builder DCF Calculator
$1.56
+$0.14 (+9.86%)
At close: Nov 16, 2026, 4:00 PM ET
$1.56
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET
+9.86%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #611/1021 (Top 60%)

Key Statistics

Market Data

Market Cap $5.79M
1D Range
1.46 1.56
52W Range
1.42 7.80

Valuation (TTM)

PE -1.24
PB 1.19
EV/EBITDA 0.12

Valuation (NTM)

Forward PE 2.75
Forward PEG -0.00
Price Target $8.00
Loading financial charts...

Profile

Can-Fite BioPharma Ltd., an Israeli clinical-stage biopharmaceutical company, specializes in the creation of small molecule therapeutic products. These treatments target a range of conditions includin...

Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Nov 6, 2012
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Apr 1, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$8.00
Upside
+412.82%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.